Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Centessa Pharmaceuticals plc ADR shares valued at $288,289 were sold by Accardi Mario Alberto on Dec 09 ’25. At $28.83 per share, Accardi Mario Alberto sold 10,000 shares. The insider’s holdings dropped to 178,801 shares worth approximately $4.44 million following the completion of this transaction.
Also, Accardi Mario Alberto purchased 10,000 shares, netting a total of over 293,000 in proceeds.
Before that, Accardi Mario Alberto had sold 10,000 shares from its account. In a trade valued at $300,000, the President, Orexin Program traded Centessa Pharmaceuticals plc ADR shares for $30.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $4.69 million.
Analysts at Stephens started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October. As of September 03, 2025, Wells Fargo has initiated its “an Overweight” rating for CNTA.
Analyzing CNTA Stock Performance
On last trading session, Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] plunged -0.52% to $24.85. The stock’s lowest price that day was $24.43, but it reached a high of $25.5 in the same session. During the last five days, there has been a drop of approximately -8.57%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have jumped approximately 48.36%. Shares of the company reached a 52-week high of $30.58 on 12/08/25 and a 52-week low of $9.60 on 04/09/25.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 24.35, which, if violated, would cause prices to drop to 23.86. In the upper region, resistance lies at 25.42. The next price resistance is at 26.00. RSI (Relative Strength Index) is 38.07 on the 14-day chart, showing neutral technical sentiment.
Is Centessa Pharmaceuticals plc ADR subject to short interest?
Stocks of Centessa Pharmaceuticals plc ADR saw a sharp rise in short interest on 2025-11-28 jumping by 0.92 million shares to 6.08 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 5.15 million shares. A jump of 15.21% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.7 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.7.
Which companies own the most shares of Centessa Pharmaceuticals plc ADR (CNTA)?
In terms of Centessa Pharmaceuticals plc ADR share price expectations, FactSet research, analysts set an average price target of 33 in the next 12 months, up nearly 32.11% from the previous closing price of $24.98. Analysts anticipate Centessa Pharmaceuticals plc ADR stock to reach 42 by 2025, with the lowest price target being 30. In spite of this, 6 analysts ranked Centessa Pharmaceuticals plc ADR stock as Buy at the end of 2025. On July 21, 2025, Truist assigned a price target of “a Buy” to the stock and initiated coverage with a $30.
